The Financial Impact of Serialisation on the Pharmaceutical Industry
Add bookmark
Counterfeit and substandard drugs kill over 100,000 people per year and may indirectly cause the death of nearly 1 million patients. In this podcast economist and author Roger Bate and IQ editor Andrea Charles, discuss the cost of counterfeit and substandard medicines to the global economy, where the greatest of counterfeiting threat comes from and the financial impact serialisation initiatives will have on the pharma industry.
[inlinead]
| Have Your Say Rate this feature and give us your feedback in the comments section below |
Tags:
Roger Bate
supply chain security
supply chain cost
serialisation
counterfeit drugs
substandard medicines
anticounterfeiting
